SCHEMBL23427231

SCHEMBL23427231

FC(F)(F)c1c2ccccc2c(-c2ccc3c(c2)oc2cccc(-c4c5ccccc5c(C(F)(F)F)c5ccccc45)c23)c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSD A5PKW4 1/20 0.36
▸ CDC14B O60729 3/20 0.35
▸ CDC14A Q9UNH5 3/20 0.35
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2E1 P05181 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP4B1 P13584 1/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ CYP3A5 P20815 1/20 0.34
▸ CYP2A7 P20853 1/20 0.34
▸ CYP3A7 P24462 1/20 0.34
▸ CYP2F1 P24903 1/20 0.34
▸ CYP2C18 P33260 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CYP2J2 P51589 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23427726 0.96 ENPP1 (0.35) PSDCDC14BCDC14ACYP1A1CYP1A2
SCHEMBL23427299 0.96 ENPP1 (0.35) PSDCDC14BCDC14ACYP1A1CYP1A2
SCHEMBL23746959 0.94 ESR1 (0.33) PSDCDC14BCDC14ACYP1A1CYP1A2
SCHEMBL23427489 0.90 CYP1A1 (0.36) PSDCDC14BCDC14ACYP1A1CYP1A2
SCHEMBL23427266 0.88 CYP1A2 (0.44) PSDCDC14BCDC14ACYP1A1CYP1A2
SCHEMBL23426829 0.87 AHR (0.42) CYP3A4AHRL3MBTL1ALOX5MEN1
SCHEMBL23427244 0.87 AHR (0.33) CDC14BCDC14AAHRL3MBTL1ALOX5
SCHEMBL23472726 0.86 MAPT (0.42) CDC14BCDC14ACYP1A1CYP1A2CYP2E1
SCHEMBL25640550 0.86 PLA2G2A (0.36) CDC14BCDC14ACYP1A1CYP1A2CYP2E1
SCHEMBL23426819 0.86 AHR (0.45) CYP3A4AHRL3MBTL1ALOX5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11991927-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-21 — — US disclosed
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 — — US disclosed
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, AOX1, OXER1 PSD 3907/4885CDC14B 4322/4885CDC14A 4283/4885
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, AOX1 PSD 3264/4885CDC14B 4150/4885CDC14A 4074/4885
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 PSD 3020/4885CDC14B 4065/4885CDC14A 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback